Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Change in Cash (2020 - 2025)

Historic Change in Cash for PROCEPT BioRobotics (PRCT) over the last 6 years, with Q3 2025 value amounting to -$8.4 million.

  • PROCEPT BioRobotics' Change in Cash rose 5132.42% to -$8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $97.5 million, marking a year-over-year increase of 20704.38%. This contributed to the annual value of $76.5 million for FY2024, which is 12119.64% up from last year.
  • Latest data reveals that PROCEPT BioRobotics reported Change in Cash of -$8.4 million as of Q3 2025, which was up 5132.42% from -$13.5 million recorded in Q2 2025.
  • In the past 5 years, PROCEPT BioRobotics' Change in Cash ranged from a high of $161.3 million in Q3 2021 and a low of -$40.9 million during Q1 2023
  • Moreover, its 5-year median value for Change in Cash was -$16.2 million (2021), whereas its average is $10.3 million.
  • The largest annual percentage gain for PROCEPT BioRobotics' Change in Cash in the last 5 years was 76735.96% (2023), contrasted with its biggest fall of 14058.25% (2023).
  • Quarter analysis of 5 years shows PROCEPT BioRobotics' Change in Cash stood at -$16.2 million in 2021, then tumbled by 69.25% to -$27.4 million in 2022, then dropped by 12.0% to -$30.6 million in 2023, then skyrocketed by 546.98% to $137.0 million in 2024, then tumbled by 106.16% to -$8.4 million in 2025.
  • Its Change in Cash stands at -$8.4 million for Q3 2025, versus -$13.5 million for Q2 2025 and -$17.5 million for Q1 2025.